Benson Capital Partners

Benson Capital Partners is a private venture capital firm founded in 2019 and based in New Orleans, Louisiana. The firm focuses on fostering new business formation, workforce expansion, and wealth creation throughout the Gulf South region. It invests in promising companies within key sectors such as tourism, logistics, health care, and energy, providing both capital and resources to support their growth. Through its investments, Benson Capital Partners aims to address significant market needs and contribute to the economic development of the area.

11 past transactions

Prokeep

Series A in 2024
Prokeep is a customer engagement platform that enhances communication for distributors by enabling text messaging capabilities for their existing phone lines. This allows contractors to send orders, images, and inquiries directly via text, streamlining interactions and improving workflow. By centralizing messaging, automating order updates, and preserving conversation history, Prokeep helps distributors of all sizes provide better service and foster positive customer experiences. The platform is designed to facilitate efficient communication, ensuring that customer needs are met promptly and effectively.

OS Benefits

Pre Seed Round in 2024
OS BENEFiTS is the first affordable health insurance and wellness benefits marketplace made for the hospitality industry

Glass Half Full

Seed Round in 2024
Glass Half aims to make glass recycling a transparent and accessible procedure that results in a product that can be used in our state.

Inclusively

Series A in 2023
Inclusively is a technology-driven employment platform focused on connecting job seekers with disabilities, mental health conditions, and chronic illnesses to inclusive employers. The platform aims to enhance workplace inclusion by facilitating the recruitment process for candidates who require accommodations under the Americans with Disabilities Act. By providing insights, access, training, and support to employers, Inclusively helps organizations attract and retain diverse talent while empowering individuals with disabilities to find suitable positions within supportive workplaces. The company recognizes the importance of addressing employment barriers for the disability community, which represents a significant portion of the workforce.

ARIX Technologies

Series A in 2023
ARIX Technologies, Inc. is a robotics and data analytics company that specializes in the design and development of crawling robots for pipeline inspection, specifically within the oil and gas sector. Founded in 2017 and headquartered in Jackson, Louisiana, with an engineering office in Houston, Texas, the company focuses on enhancing the monitoring, testing, and analysis of pipeline assets in petrochemical facilities. By integrating advanced robotics with sophisticated data analytics, ARIX Technologies aims to transform the detection and management of corrosion, thereby improving safety and sustainability in manufacturing environments. Their technology not only helps companies reduce operational costs but also enhances overall data quality, potentially leading to significant savings in manufacturing expenses.

Inclusively

Convertible Note in 2022
Inclusively is a technology-driven employment platform focused on connecting job seekers with disabilities, mental health conditions, and chronic illnesses to inclusive employers. The platform aims to enhance workplace inclusion by facilitating the recruitment process for candidates who require accommodations under the Americans with Disabilities Act. By providing insights, access, training, and support to employers, Inclusively helps organizations attract and retain diverse talent while empowering individuals with disabilities to find suitable positions within supportive workplaces. The company recognizes the importance of addressing employment barriers for the disability community, which represents a significant portion of the workforce.

Obatala Sciences

Series A in 2022
Obatala Sciences is a biotechnology company focused on addressing the economic challenges posed by obesity and diabetes, which collectively amount to a substantial financial burden. The company has developed a humanized adipose tissue model system that serves as an advanced in vitro platform for tissue engineering and drug discovery. This three-dimensional screening tool facilitates disease modeling, cell assays, and tissue analysis, thereby enabling academic and pharmaceutical researchers to identify effective drug compounds more efficiently. By emphasizing the role of body fat as a functional organ that regulates health and disease, Obatala Sciences aims to streamline the testing processes for potential treatments targeting obesity, diabetes, and related metabolic diseases.

Prokeep

Seed Round in 2022
Prokeep is a customer engagement platform that enhances communication for distributors by enabling text messaging capabilities for their existing phone lines. This allows contractors to send orders, images, and inquiries directly via text, streamlining interactions and improving workflow. By centralizing messaging, automating order updates, and preserving conversation history, Prokeep helps distributors of all sizes provide better service and foster positive customer experiences. The platform is designed to facilitate efficient communication, ensuring that customer needs are met promptly and effectively.

Conserv

Series A in 2022
Conserv is a software and sensors company revolutionizing the art conservation industry with its comprehensive platform tailored for conservation professionals. The company specializes in environmental monitoring, a vital aspect of conservation work, and has created a unique wireless monitoring system specifically designed for this purpose. Its mobile application facilitates accurate, real-time data collection, allowing users to easily set up and customize environmental standards based on the specific needs of their art collections. By integrating various conservation tasks into a single solution, Conserv aims to enhance the efficiency and effectiveness of conservation efforts.

AxoSim

Private Equity Round in 2020
AxoSim, Inc. is a biotechnology company based in New Orleans, Louisiana, specializing in the development of innovative platforms for neurological drug discovery. Founded in 2014, AxoSim focuses on accelerating the drug development process by providing advanced in vitro models that mimic the human nervous system. Its key technologies include Nerve-on-a-Chip, which predicts clinical neurotoxicity and models human neurodegenerative diseases, and NerveSim, which features human-relevant Schwann cell myelination and electrical metrics. Additionally, AxoSim offers BrainSim, a platform that supports oligodendrocyte myelination for testing in neurotoxicity. By creating 3D cell-based models that replicate the structure and function of nerve tissue, AxoSim aims to enhance the efficiency of pharmaceutical research while reducing reliance on traditional animal testing methods.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.